baber/WOPTO huggingface dataset:
Patent JP-3258966-B2 (JP)
Title: Laminated structure
Inventor: HONDA MAKOTO
IPC: E02B11/00
Filed: 1998-10-05
Granted: 2002-02-18
Abstract: Disclosed is a stacked structure capable of making easier work to be performed in the work site and improving the working efficiency. The stacked structure comprises skeleton members (50) each having mountain-shaped portions (51) with substantially mountain-like shapes successively repeated in an X-axis direction and substantially the same sectional form extending in a Y-axis direction orthogonal to the X-axis direction, the skeleton members (50) being stacked from one above another in a Z-axis direction orthogonal to the X-axis direction and the Y-axis direction to form the stacked structure. When stacking the skeleton members one above another, bottom ends (56) of the mountain-shaped portions (51) with substantially mountain-like shapes successively repeated of one of two skeleton members adjacent each other in the Z-axis direction are arranged to cross top ends (54) of the mountain-shaped portions (51) of the other skeleton member. <IMAGE>
Patent JP-2682960-B2 (JP)
IPC: A61K8/00
Filed: 1994-11-24
Granted: 1997-11-26
Abstract: Film-forming composition in aqueous medium, containing, in dispersed form, at least one film-forming material and a fluorine-containing copolymer resulting from the copolymerisation of at least one first fluorine-containing vinyl monomer and of at least one second monomer of formula (A): <IMAGE> with R1 denoting a hydrogen atom or a C1-C4 alkyl radical and R2 denoting a C1-C6 alkyl radical. This composition may be a mascara, an eyeliner, a nail varnish or a lacquer.
Patent JP-3394982-B2 (JP)
IPC: A61P35/00
Filed: 1991-11-07
Granted: 2003-04-07
Abstract: A side effect inhibitor for cancer therapy containing a hepatocyte growth factor (HGF) as the active ingredient and a method of inhibiting side effects by administering HGF. HGF can alleviate damages to normal cells and tissues and inhibit side effects in treating cancers by chemotherapy, radiotherapy or the like. Hence, it is possible to conduct more intense cancer therapy and to improve the carcinostatic effect.
Patent JP-3155262-B2 (JP)
IPC: G03H1/06
Filed: 1989-12-27
Granted: 2001-04-09
Abstract: A method of generating a quasi-complex hologram using incoherent light and a conoscope system comprising a birefringent crystal (30) inserted between two circular polarizers (10, 20), the method comprising the following steps: (i) recording a plurality of different conoscopic holograms of the same object without relative displacement thereof and with respective different polarization configurations; and (ii) combining the various conoscopic holograms obtained in this way in order to remove the bias and the conjugate image. The invention also relates to a device for implementing the method.
Patent JP-3124480-B2 (JP)
IPC: H01L21/77
Filed: 1995-12-12
Granted: 2001-01-15
Abstract: In order to obtain a thin-film transistor having high characteristics using a metal element for accelerating the crystallization of silicon, a nickel element is selectively added to the surface of an amorphous silicon film (103) in regions (101) and (102) and regions (108) to (110), and a heat treatment is carried out to grow crystals (horizontal growth) in directions parallel to the substrate as indicated by arrows (104) to (107). At this point, the regions (108) to (110) having a width of 5 mum or less serve as stopper regions so that horizontal growth starting from the regions (101) and (102) stops there. In this way, the horizontal growth regions can be formed with high controllability. Then a circuit such as a shift register can be constructed with a region having the same crystal growth form.
Patent JP-2683264-B2 (JP)
IPC: A61M15/06
Filed: 1988-03-22
Granted: 1997-11-26
Abstract: A plaster containing active ingredients for controlled administration of active ingredients to the skin and possessing a rear side and a skin side, has a rear layer, an active ingredient reservoir containing one or more active ingredients arranged essentially perpendicular to the surface of the plaster in contact with the skin, and an adhesive device on the skin side and possibly a covering layer which is detached before application of the plaster. At least one active ingredient reservoir part (12) can be detached on to the skin while one or more active ingredient reservoir parts remain. For this purpose, the part (13) of the active ingredient reservoir remaining on the skin adheres more strongly to the skin than to the rear side (11).
Patent JP-3868003-B2 (JP)
IPC: D06M15/11
Filed: 1997-06-20
Granted: 2007-01-17
Abstract: A process for preserving a liquid laundry starch concentrate containing starch or starch derivatives suspended in an aqueous xanthan solution by adding to the concentrate ethanol and a quaternary ammonium compound corresponding to general formula (I):In which R1 and R2 independently of one another represent a linear or branched alkyl group containing 8 to 18 carbon atoms and A- is a charge equalizing anion.
Patent JP-3268646-B2 (JP)
IPC: G08B13/194
Filed: 1992-09-11
Granted: 2002-03-25
Abstract: In a method and apparatus for analysing an electronic image signal, the signal is treated as representing one or more cells each comprising a plurality of pixels. A set of pointers is generated and sequentially set according to characteristic values related to detailed image content. The pointers are used to address a memory array and for successive frames, the value of an address in each array row indicated by the pointer corresponding to that row is updated. In this way, for each frame the characteristic values can be accumulated so that in a single operational mode, both a time history of the image, stored in a memory, is updated and an indication is produced indicative of the occurrence or non-occurrence of an event not associated with image background. The characteristic values can be generated by randomly or pseudo-randomly selecting pairs of pixels and for each, generating a binary signal depending on whether or not the intensity of incident light on a predetermined one of the pair is greater than the intensity on the other. Over all the rows, the values in the addresses being updated can be summed, as well as the maximum value in each row. The ratio of the two sums can be time weighted averaged with respect to the ratios obtained from previous frames. The ratio is compared with the average and the result used to determine the occurrence or non-occurrence of a significant event within the image. <IMAGE>
Patent JP-4225569-B2 (JP)
IPC: G02B6/42
Filed: 1996-07-12
Granted: 2009-02-18
Abstract: A removable light source is provided for use with the optical coupling system. The light source is mounted to a removable assembly for slidable insertion into, and removed from, a housing containing the optical coupling system. The removable assembly includes positioning elements for maintaining precise alignment of the light source with optical components mounted within the housing. In one embodiment described herein, precise alignment is achieved by employing six mounting pads on outside surfaces of a base of the removable assembly. Three of the mounting pads are aligned along a first plane. Two are aligned along a second plane perpendicular to the first. The remaining pad is aligned along a third plane perpendicular to both the first and second planes. The light source is mounted to the base in a precise fixed relationship with the mounting pads. The removable assembly is inserted within a slot formed in the housing of the optical coupling system. Upon insertion, the mounting pads lie against mutually perpendicular interior walls of a receiving block of the housing. The mounting pads thereby ensure that the light source is precisely positioned with respect to the receiving block. Optical components within the housing are mounted in a precise fixed relationship with the receiving block. Accordingly, while inserted, the light source is maintained in precise alignment with the receiving block and thereby also in precise alignment with the optical components.
Patent JP-3281365-B2 (JP)
IPC: H01J29/02
Filed: 1989-07-03
Granted: 2002-05-13
Abstract: A flat panel display of the field emission cathode type is described having polyimide spacers or pillars separating the emitting surface and display face of the same. A method of forming the spacers by integrated circuit techniques also is described.
Patent JP-3549884-B2 (JP)
IPC: B05B17/06
Filed: 1993-10-15
Granted: 2004-08-04
Abstract: The device is designed for nebulizing liquids and for transporting the formed aerosols. It includes components to form a fountain of liquid that is being nebulized, a container holder (4), a container (2) with contact medium (3), an additional container (5) with liquid being nebulized (6), a nebulization chamber (7), a system for transporting the aerosol to the user, an outlet duct (11), and a mechanism for regulation of rate of delivery of aerosol. The nebulization chamber (7) is designed as a double-element structure, composed of an intake tube (8) and an expansion chamber (9). In the bottom of the expansion chamber (9) outlets (10) have been made for the drainage of the non-nebulized liquid back to the section of the container remote from the base of the fountain. This reduces the negative action of the non-nebulized liquid on the effectiveness of nebulization. The expansion chamber (9) which is incorporated into the nebulization chamber (7) ensures a significant reduction in coagulation of the aerosol particles, thus increasing the efficiency of the nebulizer and particle uniformity. The latter effect is likewise heightened by this specifically designed outlet duct (10) which accomplishes a process of gravitational filtration. As a consequence of the movement of the stream in the narrow intake tube (8) there is formation of a differential pressure, enabling transport of the aerosol from the nebulization chamber to the user. The above principles are proposed for application to multi-use and single-used devices.
Patent JP-4177455-B2 (JP)
IPC: C07H21/00
Filed: 1996-08-16
Granted: 2008-11-05
Abstract: The invention relates to modified oligonucleotides that are useful for studies of gene expression and for the antisense therapeutic approach. The invention provides inverted hybrid oligonucleotides and inverted chimeric oligonucleotides, both of which produce reduced side effects, relative to traditional phosphorothioate, hybrid or chimeric oligonucleotides.
Patent JP-3465191-B2 (JP)
IPC: C04B41/52
Filed: 1993-10-15
Granted: 2003-11-10
Abstract: PCT No. PCT/GB93/02132 Sec. 371 Date Aug. 2, 1995 Sec. 102(e) Date Aug. 2, 1995 PCT Filed Oct. 15, 1993 PCT Pub. No. WO94/08917 PCT Pub. Date Apr. 28, 1994A method of treating earthenware bodies to enhance resistance to freezing and to assist the application of decals and the like thereto comprises treating the bodies with a liquid medium containing a water-repellent material such as silicone. In a subsequent drying step, the bulk of the liquid medium is removed while leaving the water-repellent material deposited in the pores of the earthenware body. In this way, subsequent entry of water and freezing and cracking is resisted. It has also been discovered that the treatment also enchances the ability of the earthenware surface to receive decals and the like without the need for glazing and an additional firing step.
Patent JP-3710473-B2 (JP)
IPC: A61K9/52
Filed: 1994-10-06
Granted: 2005-10-26
Abstract: A tablet containing enteric granules prepared by tableting a mixture of enteric granules containing a basis with at least one member selected from the group consisting of synthetic hydrotalcite, dried aluminum hydroxide gel, a coprecipitate of aluminum hydroxide with sodium hydrogencarbonate, aluminum magnesium hydroxide, synthetic aluminum silicate and dihydroxyaluminum aminoacetate. As compared with the conventional tablets containing coated granules, this tablet has the following advantages: the content of enteric granules is increased by using a specified filler; the basis is rapidly dispersed in the granules; the granules have drug-release ability and acid resistance comparable to those before tableting; damage to the coating is reduced; weight variation during tableting is reduced; and the tablet has a high strength. The technique of preparing a tablet having a high enteric granule content has merits of an improved administrability due to a reduced size of the tablet and the applicability to other drugs.
Patent JP-4157603-B2 (JP)
IPC: A61F7/00
Filed: 1997-10-16
Granted: 2008-10-01
Abstract: PCT No. PCT/SE97/01735 Sec. 371 Date Apr. 16, 1999 Sec. 102(e) Date Apr. 16, 1999 PCT Filed Oct. 16, 1997 PCT Pub. No. WO98/16176 PCT Pub. Date Apr. 23, 1998The present invention relates to an apparatus for regulating the temperature of the scalp of a person undergoing chemotherapy or like treatment, for instance. The apparatus comprising a head covering (1) that includes a plurality of chambers (4) that extend from the edge (5) of the head covering up towards the crown (7) of said covering, such that the coolant inlets (9) are located at the bottom of the head covering in the vicinity of its edge (5) and the outlets (10) are located at the top of the head covering in the vicinity of its crown (7).
Patent JP-3262171-B2 (JP)
IPC: A61M25/06
Filed: 1991-10-15
Granted: 2002-03-04
Abstract: A transseptal left atrial cannulation system which provides drainage of left atrial blood without the need for thoracotomy. A guide wire and a long needle assembly are inserted into a catheter. A cannula rides over the exterior of this catheter. The guide wire may be advanced past the needle assembly and through a catheter through the distal end of the catheter to assist in directing the system to the right atrium. The cannulation system is inserted in a femoral vein located in the groin. Both the guide wire and needle assembly are long enough to allow a substantial length to extend out of the body at the groin for manipulation even when the distal ends of the guide wire and needle assembly are positioned in the heart. When the catheter distal end is positioned adjacent the septum in the right atrium, the guide wire is withdrawn from the catheter orifice and the needle assembly moves past the guide wire and through the catheter orifice to a position adjacent to the septum. The needle pierces the septum and the catheter moves over the needle assembly to further dilate the septal hole. The cannula attached to the catheter also moves through the septal hole, further dilating it, and resting with the holes in the left atrium. The guide wire, the needle assembly, and the catheter are withdrawn from the cannula. Oxygenated blood from the left atrium drains through the cannula to the extracorporeal pump and back to the body through an arterial cannula.
Patent JP-3083102-B2 (JP)
IPC: A61P31/04
Filed: 1995-02-02
Granted: 2000-09-04
Abstract: A compound having the formula     <IMAGE>  (IV)  wherein Z is CH2-N(CH3), N(CH3)-CH2, or    <IMAGE>   R1 and R2 are selected from 1) one of R1 and R2 is OH and the other of R1 and R2 is (C1-C6)alkyl, (C2-C6)alkenyl, or phenyl, with the proviso that Z is not CO; 2) one of R1 and R2 is H and the other of R1 and R2 is NR5R6 wherein R5 and R6 are independently selected from H and (C1-C6)alkyl, or is OR7 wherein R7 is H or (C1-C6)alkyl; and 3) R1 and R2 together form an oxo or oxime group; R3 and R4 are each hydroxyl or together form a carbonate or thiocarbonate group; and pharmaceutically acceptable salts thereof.
Patent JP-3047122-B2 (JP)
IPC: C09D5/36
Filed: 1995-04-26
Granted: 2000-05-29
Abstract: Coating compositions are disclosed, suitable for use as base paints for multiple layer coatings, whose perceived colour depends on the angle from which they are viewed. They contain: one or more binders usually used in such coatings; one or more scale-type pigments the hue of which depends on the angle from which they are viewed, these pigments consisting of oriented, three-dimensionally cross-linked substances of chiral phase, liquid crystalline structure; one or more usual effect pigments which differ from the said scale-type pigments; optionally one or more cross-linking agents; optionally one or more colour-imparting absorption pigments and/or fillers; and optionally additives usually used in coatings of this type.
Patent JP-3354156-B2 (JP)
IPC: B03D1/14
Filed: 1997-02-12
Granted: 2002-12-09
Abstract: A method and apparatus for feeding coolant liquid to a lathe with a nozzle (53) having a discharge port (58) of substantially rectangular cross section and a constricted curved surface portion (62) on its inner wall to produce a turbulent flow and a loosely mounted tongue piece (59) crossing the section of the discharge port and projecting outside the port. The coolant is thus discharged as a collection of particulate turbulent flows containing air bubbles drawn into the coolant liquid as it passes by the tongue piece. The coolant is caused to impinge on the rotating peripheral surface (56) which is continuous with the region of the workpiece in contact with the cutter (57). <IMAGE>
Patent JP-3664737-B2 (JP)
IPC: A23L1/30
Filed: 1998-03-18
Granted: 2005-06-29
Abstract: A therapeutic or preventive agent for diabetes mellitus which is characterized in containing at least one compound selected from a group consisting of 4,5-dihydroxy-2-cyclopenten-1-one represented by the following formula ÄIÜ and an optically active substance and a salt thereof as an effective component. <CHEM>
Patent PL-160140-B2 (PL)
Title: Device for loading bags with flowing material with  tendency for aggregation and lumping
IPC: B65B1/06
Filed: 1989-12-15
Abstract: The invention concerns a device for sacking with loose material prone to adhesion and agglomeration, composed of a framework, fitted with motors to drive worm conveyors and a belt conveyor, characterised in that in the upper part of the framework (1), a bidirectional belt conveyor (4) is installed, whereas chute channels (9) are located on ends of that conveyor, whereas two-part chute sleeves (10) are attached to those chute channels via articulated joints, and below the said chute sleeves, symmetrically in relation to the longitudinal axis, a belt conveyor (14) is attached to the framework (1), stands (13) are attached on the said conveyor, and a worm conveyor (20) is located below the belt conveyor (14).<IMAGE>
Patent ES-2337324-B2 (ES)
Title: Broche sujetador de documentos elastico extensible.
Inventor: TIRADO ALANIS JUAN ROBERTO
IPC: B42F13/02
Filed: 2005-08-08
Granted: 2011-01-31
Abstract: Broche sujetador de documentos elástico
extensible. 
     La presente invención se refiere a un broche
sujetador elástico extensible, que nos permite sujetar desde un solo
documento, hasta la extensión o grueso de documentos que se
necesite, ya que su elemento elástico se puede obtener en todos los
largos que se requiera pudiendo fácilmente hacerle punta en sus
extremos para que se guíe mejor en los documentos, la sujeción se
hace en una forma práctica y rápida sin maltratar los papeles,
pudiendo meter o sacar prácticamente en cualquier momento papeles
siendo de gran resistencia y versatilidad para todo tipo de clima,
sin manchar sus documentos, eliminando el cosido de documentos o los
broches tradicionales que se ha demostrado maltratan los documentos,
ahorrando tiempos, costes y deformación de documentos, muy adecuado
para la conservación de archivos de cualquier índole. Teniendo
además la ventaja de poder ver información que se encuentre
escondida en el centro cerca del broche sin correr el riesgo de
romper los documentos ya que es elástico.
Patent ES-2368276-B2 (ES)
Title: Compuestos derivados de bis-benzamidinios como agentes fluorogénicos para señalizar secuencias específicas de adn de doble cadena.
Inventor: VAZQUEZ VAZQUEZ OLALLA
IPC: C07C257/18
Filed: 2010-04-27
Granted: 2012-06-28
Abstract: Compuestos derivados de bis-benzamidinios como agentes fluorogénicos para señalizar secuencias específicas de ADN de doble cadena. La presente invención se refiere a un grupo de compuestos de estructura benzamidinica, a su procedimiento de síntesis y a su uso como agentes f1uorogénicos de reconocimiento de secuencias de ADN.
Patent ES-2387440-B2 (ES)
Title: Formulaciones topicas de anfotericina b y metodo de obtencion
Inventor: TORRADO DURAN JUAN JOSE
IPC: A61K31/7048
Filed: 2010-09-27
Granted: 2014-02-04
Abstract: La invención se refiere a la preparación de nuevas formulaciones de anfotericina B de administración por vía tópica. En dichas formulaciones, la anfotericina B se encuentra formando un complejo con ciclodextrina. La poca afinidad de la anfotericina B por la ciclodextrina provoca la liberación de la mayor parte del antifúngico tras la administración de la formulación, ocasionando un aumento del efecto farmacológico de la anfotericina B gracias al cual ésta manifiesta acción antiparasitaria (antileishmaniosis) además de la acción antimicótica (cutánea, mucocutánea y superficial), principal indicación para la que se prescribe actualmente la anfotericina B. Para la preparación de estas formulaciones se utiliza una combinación de excipientes (además de la ciclodextrina que actúa como solubilizante), tales como viscosizantes, emulsificantes y excipientes grasos. En la presente invención se describe la preparación de formulaciones tópicas de anfotericina B, presentando cada o una de ellas una forma farmacéutica diferente: gel, crema, pomada y colirio.
Patent ES-2526492-B2 (ES)
Title: Sistema automático y procedimiento de carga y descarga de contenedores
Inventor: CALLEJON FERNANDEZ JOSÉ
IPC: B65G69/00
Filed: 2013-07-08
Granted: 2015-11-03
Abstract: Sistema automático de carga y descarga de contenedores que comprende una plataforma fija (4) que apoya y es paralela al suelo, una horquilla extensible (5) desplazable con respecto a la plataforma fija (4) en sentido al contenedor (2) o en sentido contrario, medios de deslizamiento (6) de la horquilla extensible con respecto a la plataforma fija, medios portadores (7) de mercancía (1), medios de elevación neumática (8) del conjunto de los medios portadores (7) y la propia mercancía (1) dispuesta sobre los mimos y de la horquilla extensible (5) y medios de anclaje y alineación (9) de la plataforma fija (4) a la embocadura (3) del contenedor (2). La horquilla extensible (5) adopta una posición retraída en la cual queda situada ocupando su longitud la totalidad de la longitud de la plataforma fija (4) y una posición extendida en la cual se ha desplazado con respecto a la plataforma fija (4) sobresaliendo de la misma.
Patent ES-2610203-B2 (ES)
Title: Unidad para la formación de cubiertas transitables
Inventor: LOZANO MORENO DIEGO
IPC: E04D13/04
Filed: 2016-12-09
Granted: 2017-09-11
Abstract: Unidad para formación de cubiertas transitables, que está compuesta por un panel de base (1) de naturaleza aislante, un soporte (2), que apoya y va fijado sobre el panel de base (1); una bandeja (3) que va montada sobre el soporte (2) de fijación; una rejilla (4) que va montada sobre la bandeja (3); y un colector (5) en el que vierte la bandeja (3).
Patent AU-2001257063-B2 (AU)
Title: Topical formulations for the transdermal delivery of niacin and methods of treating hyperlipidemia
Inventor: QASEM JABER G
IPC: A61K9/70
Filed: 2001-04-16
Granted: 2005-04-28
Abstract: Niacin and niacin prodrugs are topically administered as suitable formulations to device for impoving the lipid profiles of subjects, preferably humans.
Patent AU-2002237853-B2 (AU)
Title: Rigid hull inflatable boat with foam insert
Inventor: HANSEN WILLIAM
IPC: B63B1/00
Filed: 2002-01-14
Granted: 2006-06-01
Abstract: A boat with an inflatable collar mounted on the sides of the hull. The inflatable collar extends outwardly from the sides of the hull so that it contacts and displaces an increasing volume of water as the boat lists. The inflatable collar is partially filled with foam and the foam inserts are sized so that the boat retains a sufficient righting moment for its intended purpose, even when the inflatable collar has lost its water- and air-tight integrity. The foam inserts may also be sized to provide the boat with sufficient buoyancy to ensure that the boat will float even if filled with water or capsized.